TrialInternational journal of hematology2016

Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study.

Kazuo Muroi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.